Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06 Noviembre 2024 - 8:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant To Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
| ☐ |
Preliminary
Proxy Statement |
| ☐ |
Confidential,
for Use of the Commissions Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ |
Definitive
Proxy Statement |
| ☒ |
Definitive
Additional Materials |
| ☐ |
Soliciting
Material Pursuant to Section 240.14a-12 |
| MICROBOT
MEDICAL INC. |
| (Name
of Registrant as Specified in its Charter) |
| N/A |
| (Name
of Person(s) Filing Proxy Statement, if other than the Registrant) |
Payment
of Filing Fee (Check all boxes that apply):
| ☒ |
No
fee required. |
| |
|
| ☐ |
Fee
paid previously with preliminary materials |
| |
|
| ☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Microbot Medical (NASDAQ:MBOT)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Microbot Medical (NASDAQ:MBOT)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
